Veristat launches clinical trial, biostatistics, and programming operations in Taipei, Taiwan in response to increasing client demand for regulatory submission support for both local and North American-based sponsors.
Parexel forms a strategic partnership with Clariness to deploy the ClinLife platform in the Greater China area as the CRO looks to recruit and engage patients in their native language and via social media channels.
Novo Nordisk Pharmatech selected DKSH to distribute its pharmaceutical grade compounds to the company’s growing customer base in the Asia-Pacific region.
The Switzerland-headquartered contract research organization (CRO) has opened offices in Taiwan following a string of investments in the Asia Pacific region.
CRO Clintec International has opened offices in China, Singapore and Thailand in a move designed to consolidate its presence in the Asia Pacific region.
The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.
Parexel has opened two offices in China, expanding its presence in Asia Pacific to 17 sites, as part of efforts to provide cheaper, faster drug development services.
SIRO Clinpharm has formed an alliance with South Korea-based CRO DreamCIS to expand its clinical trial offering in Asia Pacific and provide clients with more options for patient recruitment.
As clinical trial activity in the Asia Pacific region continues to
boom, Novotech, the largest Australian owned contract research
organisation (CRO) has presented a checklist to help pharma firms
minimise risk when choosing a partner.
Top international clinical research organisation (CRO) Quintiles is
celebrating after winning two industry awards for its work in the
Asia Pacific region.